Patents by Inventor Arvid Wretlind

Arvid Wretlind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5445811
    Abstract: Disclosed are emulsions for intravenous administration based on lipophilic iodized and/or bromated substances with emulsifiers and containing derivatives of cyclopenta-phenanthrene, wherein the weight ratio between emulsifier and derivative in the emulsion is between 10:1 and 1:2. These emulsions are intended for use as X-ray contrast agent, particularly for visibilizing the presence of tumors, metastases and the like in liver and spleen. The derivative of cyclopenta-phenanthrene is preferably cholesterol, phytosterol, sitosterol, sigmasterol and/or campesterol. The invention also relates to a method for preparing the emulsion and to the use of the emulsion in the preparation of an X-ray contrast medium for computed tomographic examinations.
    Type: Grant
    Filed: December 7, 1993
    Date of Patent: August 29, 1995
    Assignee: Pharmacia AB
    Inventors: Bjorn Norrlind, Arvid Wretlind
  • Patent number: 5093044
    Abstract: The invention relates to a nutrient for humans and animals, which is characterized in that the nutrient contains at least one non-readily water-soluble glyceride of at least one keto acid or hydroxy acid. The nutrient can be administered together with food, or in the form of an emulsion of the glyceride.
    Type: Grant
    Filed: June 27, 1990
    Date of Patent: March 3, 1992
    Assignee: Kabivitrum AB
    Inventors: Arvid Wretlind, Bengt Ajaxon